Figure S6 from Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel

Open Access

Publisher Website

31 March 2023

other
Published by American Association for Cancer Research (AACR)

https://doi.org/10.1158/1078-0432.22474938.v1

Abstract

Myeloid and Tregs associated with severe CRS in patients treated with axi-cel.

Keywords